Gentueri Inc. Receives FDA Facility Registration and Device Listing

December 14, 2020

Gentueri Inc., a crisis innovator leading in the fight against COVID-19, received confirmation of its FDA Facility Registration and Device Listing.

Gentueri Inc, founded by Randy Nagy in 2012, specializes in advancing the collection, preservation, and processing of biological samples with innovative devices and kits.

Historically, Gentueri has provided DNA collection kits to the forensic market, launching some of the most innovative DNA collection devices in the market. But shortly after the COVID-19 crisis began, Gentueri pivoted sharply. Recognizing the threat early on, the company extended its production to include COVID-19 test kits.

The new facility is four times the size of its previous location and will allow the company to increase capacity, expedite orders, add new innovative products, and serve customers with quality products.

Randy Nagy, founder of Gentueri commented, “Obtaining FDA Registration of our new larger facility represents an important step in our expansion plans as we significantly increase capacity and meet the requirements of new medical device markets. We are also proud to continue our fight against COVID-19 with our new product listings for Viral Transport Media Kits and our PBS Response Kit.”

In compliance with the Unique Device Identification (UDI) requirements, the company is now approved by the FDA to manufacture and distribute both its Viral Transport Media Kits (VTM) and PBS Response Kits. The kits are helping to facilitate COVID-19 testing for residents across the state of Wisconsin as well as neighboring states.

Gentueri plans to use their new, larger medical device facility to expand its ability to fight COVID-19, enter new markets and design innovative biospecimen collection devices that collect samples easily and preserve them at room temperature, enabling convenient integration into downstream automated analytical systems.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes. The new analytical instrument is designed to be easily reconfigurable, providing those who require determination of ionic and small polar compounds with a one stop shop for consistent, reliable ion analysis.
This new collaboration is another example of Blacksmith's creative deal-making with top tier partners that bring expertise to the table which helps de-risk and accelerate scientific discoveries for the development of valuable products.
Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL), is indicated as an anticoagulant to maintain catheter patency.
Through this agreement, RaySearch acquires full ownership of all rights to the product DrugLog for its application in the field of oncology, including the measuring device, calibration parameters, source code, as well as intellectual property rights.
Anna Kazanchyan, MD, Founder and CEO of Saghmos Therapeutics. "We are very pleased to announce the Notice of Allowance for our second patent, which will enhance the long-term value of ST-62516. Saghmos continues to build its intellectual property estate."

By using this website you agree to accept Medical Device News Magazine Privacy Policy